MedTrace Logo

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry

NCT03604133 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-01-22

No results posted yet for this study

Summary

The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.

Conditions

Sponsors & Collaborators

  • Cardio Surgical Partners

    collaborator NETWORK

  • QuesGen Systems Inc

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-24
Primary Completion
2023-08-24
Completion
2028-08-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03604133 on ClinicalTrials.gov